
51 - 200 employees
🧬 Biotechnology
🏥 Healthcare
🔬 Science
🔥 Funding within the last year
💰 Post-IPO Equity on 2026-02
Biotechnology • Healthcare • Science
Insight Molecular Diagnostics is a clinical molecular diagnostics company providing precision diagnostics for oncology and transplantation. iMDx operates CLIA-certified and CAP-accredited laboratories and focuses on accurate, clinically meaningful molecular testing to enable early detection and personalized treatment. Their specialties include molecular diagnostics, non-invasive liquid biopsy, and targeted diagnostics for lung and breast cancer, with an emphasis on accessibility and improving patient outcomes.
📡 We watch Insight Molecular Diagnostics's careers page
Several times a day
how often we check
3
roles posted in the last 30 days
Selected: 🆕 Date Added.
🕒 October 15
Field Clinical Applications Specialist supporting iMDx oncology and transplant molecular diagnostic products. Providing laboratory training, assay implementation, validation, troubleshooting, and market intelligence.
🇺🇸 United States – Remote
💵 $130k - $140k / year
🔥 Funding within the last year
💰 Post-IPO Equity on 2026-02
⏰ Full Time
🟡 Mid-level
🟠 Senior
✨ Clinical Specialist
👻 Ghost score 7%
🕒 October 15
Director developing commercial RUO strategies for iMDx’s oncology and transplant molecular diagnostics portfolio. Driving market intelligence, KOL relationships, Early Access Programs, and product adoption.
🇺🇸 United States – Remote
💵 $180k - $200k / year
🔥 Funding within the last year
💰 Post-IPO Equity on 2026-02
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 7%
🕒 October 6
Clinical Liaison driving transplant KOL engagement and market adoption for a precision diagnostics company. Building physician relationships, supporting product advocacy, and coordinating cross-functional commercial initiatives.
🇺🇸 United States – Remote
💵 $150k - $175k / year
🔥 Funding within the last year
💰 Post-IPO Equity on 2026-02
⏰ Full Time
🟠 Senior
✨ Clinical Liaison
👻 Ghost score 7%